• Acetylspiramycin in Resistance Research

  2026-08-14

  Acetylspiramycin (Spiramycin B) is a 16-membered macrolide for connecting ribosomal mechanism studies with practical susceptibility testing. Its lower MIC profile than erythromycin and azithromycin in a Beijing Mycoplasma pneumoniae isolate study makes it a useful comparator for antimicrobial resistance research, while its reported immune effects support carefully separated host-pathogen experiments.

• Metastatic Evolution and CRC Therapeutic Heterogeneity

  2026-08-14

  Cho and colleagues combined patient-derived xenografts with whole-exome, transcriptomic, and DNA-methylation analyses to show that colorectal cancer metastases can diverge through coordinated genetic and regulatory evolution. Their findings explain why treatment responses may differ between metastatic sites and support multi-site, evolution-aware testing in translational colon cancer research.

• Partial BACE Inhibition and Synaptic Transmission

  2026-08-13

  Satir et al. show that moderate β-secretase inhibition can reduce amyloid-beta secretion by up to 50% without impairing synaptic transmission in cultured rat cortical neurons. The study identifies a potential functional window for BACE inhibitor research while showing that stronger inhibition was associated with reduced neuronal transmission.

• Gap26: Connexin 43 Signaling Workflows

  2026-08-13

  Gap26 enables acute, concentration-controlled disruption of connexin 43 communication in calcium, ATP, vascular, and inflammatory assays. This workflow-focused guide translates macrophage evidence into practical controls, dosing decisions, and troubleshooting steps without treating hemichannel blockade as a universal substitute for genetic validation.

• MG-262: A Proteostasis Lens on Lung Cell Fate

  2026-08-12

  MG-262 (Z-Leu-Leu-Leu-B(OH)2) can be used not only to inhibit the proteasome, but also to test how proteostasis shapes inflammatory and survival responses in lung epithelial models. This article translates BIRC2/BIRC3 findings into a rigorous, reversible assay strategy.

• Tamsulosin: Bench Workflows for α1A Research

  2026-08-12

  Tamsulosin connects α1A-receptor pharmacology with practical models of ureteral propulsion, bladder-neck relaxation, and postoperative urinary retention. This workflow-focused guide covers compound handling, concentration design, functional readouts, and troubleshooting for reproducible urological disease research.

• NSC 87877: Reliable Shp2 Inhibitor Workflows

  2026-08-11

  A scenario-based guide to using NSC 87877 (SKU A4544) in viability, proliferation, cytotoxicity, and Shp2 signaling experiments. It connects biochemical potency, formulation, assay controls, and neuroinflammation evidence to practical laboratory decisions.

• AZD1480: Rewiring JAK2/STAT3 Translational Strategy

  2026-08-10

  AZD1480 is a potent JAK2 inhibitor that enables researchers to interrogate tumor-intrinsic STAT3 signaling, immune-mediated escape, myeloma biology, and combination-treatment response. This thought-leadership perspective connects the IL-6/JAK2/STAT3 feedback mechanism revealed by IDO1-inhibition research with practical experimental strategies for translational oncology.

• Inducing Right Ventricular-Like Cardiomyocytes from hPSCs

  2026-08-09

  Saito and colleagues developed a modified GiWi differentiation strategy that shifts human pluripotent stem cell cardiac progenitors toward an anterior second heart field-like identity and generates right ventricular-like cardiomyocytes. The resulting cells differed from left ventricular-like controls in gene expression, spontaneous contraction, calcium handling, and cell size, providing a useful platform for chamber-specific disease modeling.

• GS967 Cardiac Late Sodium Current Workflows

  2026-08-08

  GS967 enables targeted interrogation of pathological late sodium influx across ventricular myocyte, isolated-heart, and aging-myopathy models. This practical guide connects dose selection, electrophysiology, contractile readouts, arrhythmia challenges, and troubleshooting for reproducible cardiac research.

• Hexetidine (NSC-17764) Oral Assay Workflows

  2026-08-07

  Hexetidine (NSC-17764) supports quantitative testing across planktonic bacteria, Candida albicans, and established oral biofilms. This workflow-focused guide connects MIC determination, matrix interference, copper-ion combination studies, and saliva persistence to practical oral infection and dental plaque research.

• 2X HyperFusion High-Fidelity Master Mix: Precision for Compl

  2026-08-07

  Discover how the 2X HyperFusion High-Fidelity Master Mix empowers next-generation PCR with unmatched fidelity—enabling advanced applications in CRISPR engineering, immunotherapy research, and high-accuracy DNA amplification. Gain practical, protocol-driven insights not found elsewhere.

• Optimizing mRNA Delivery with ARCA Cy3 EGFP mRNA (5-moUTP)

  2026-08-06

  ARCA Cy3 EGFP mRNA (5-moUTP) uniquely combines direct fluorescent labeling and 5-methoxyuridine modification to deliver robust, low-immunogenicity mRNA tracking and expression in mammalian cells. This guide translates advanced delivery science and new lipid innovations into actionable, reproducible bench workflows.

• Camptothecin: Topoisomerase I Inhibitor Workflows & Innovati

  2026-08-06

  Camptothecin empowers researchers to probe DNA damage, autophagy, and adaptive mutagenesis with precision. This article delivers evidence-backed protocols, troubleshooting strategies, and unique insights from prion-driven mutagenesis studies, enabling reproducible results in cancer research and genome stability assays.

• Cefotaxime in Antimicrobial Resistance Research: Innovations

  2026-08-05

  Explore the advanced role of Cefotaxime, a third-generation cephalosporin antibiotic, in antimicrobial resistance research. This article offers unique insight into protocol design, transmission dynamics, and practical assay considerations distinct from existing workflows.

452 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page